News und Analysen
3 Drug Stocks Hitting 52-Week Highs: Are They Buys?
October has often been a scary month for stocks. That isn't the case so far this year, though. And it's especially not true for three drug stocks.Biogen (NASDAQ: BIIB), Halozyme Therapeutics....
Should Intuitive Surgical Be Worried About Tiny TransEnterix?
TransEnterix (NYSEMKT: TRXC) shareholders have every reason to be excited. The U.S. Food and Drug Administration cleared the way for the company to market its Senhance Surgical Robotic System on....
Where Will Opko Health Inc. Be in 5 Years?
Opko Health (NASDAQ: OPK) has had a rough year no matter how you look at it. So far in 2017, shares of the pharmaceutical and diagnostics company are down more than 20%. At one point, Opko stock....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Why Exelixis, Inc. Rose Higher Today
Exelixis (NASDAQ: EXEL) is up 24% at 12:21 p.m. EDT after announcing that the phase 3 Celestial trial met its primary endpoint of helping liver cancer patients taking Cabometyx live longer than....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
3 Marijuana Stocks That Like to Live Life Dangerously
In case you haven't noticed, marijuana stocks are absolutely on fire. Many of the largest pot stocks by market cap have seen their valuations double, triple, or perhaps head even higher over the....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....
Why Antares Pharma Inc Plummeted Today
Shares of Antares Pharma (NASDAQ: ATRS) are down 38% at 2:36 p.m. EDT after the company said -- in not so many words -- that it expects the Food and Drug Administration to reject the marketing....
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
BASTIDE : Nombre d'actions et de droits de vote au 30 septemebre 2017
BASTIDE LE CONFORT MEDICAL
Société Anonyme au capital de 3.303.261 euros
Siège social : 12 avenue de la Dame, Zone Euro 2000
30132 Caissargues
RCS de NIMES N° B 305 635 039
DROITS DE....
3 Growth Stocks at Value Stock Prices
It's not surprising that after an eight-year bull market, some are saying value investing is dead. With the cyclically adjusted P/E ratio of the S&P running at a red-hot 31, finding a value....
Exact Sciences Stock Just Hit an All-Time High: Here's Why It Could Go Even Higher
In May, Andrew Left of Citron Research blasted Exact Sciences (NASDAQ: EXAS), calling the stock "a poster child for what goes wrong when Wall Street gets a hold of a healthcare concept with no....
3 Healthcare Value Stocks
When value investors search through 10-Ks and valuation ratios for stocks selling on the cheap, healthcare isn't typically a sector full of stocks selling at a deep discount. When those stocks go....
3 Healthcare Value Stocks
When value investors search through 10-Ks and valuation ratios for stocks selling on the cheap, healthcare isn't typically a sector full of stocks selling at a deep discount. When those stocks go....
3 Healthcare Value Stocks
When value investors search through 10-Ks and valuation ratios for stocks selling on the cheap, healthcare isn't typically a sector full of stocks selling at a deep discount. When those stocks go....
Why 2017 Could Be This Stock's Best Year Yet
Nearly five years ago, Abbott Labs spun off its biopharmaceutical unit into a separate entity. That new company, AbbVie (NYSE: ABBV), enjoyed a tremendous first year, with its share price soaring....
Why 2017 Could Be This Stock's Best Year Yet
Nearly five years ago, Abbott Labs spun off its biopharmaceutical unit into a separate entity. That new company, AbbVie (NYSE: ABBV), enjoyed a tremendous first year, with its share price soaring....
Why 2017 Could Be This Stock's Best Year Yet
Nearly five years ago, Abbott Labs spun off its biopharmaceutical unit into a separate entity. That new company, AbbVie (NYSE: ABBV), enjoyed a tremendous first year, with its share price soaring....
Why High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt Cheap
If 2017 ended today, Aurinia Pharmaceuticals (NASDAQ: AUPH) would rank as one of the biggest winners of the year among biopharmaceutical stocks. Aurinia's share price has more than tripled so far....
2 Reasons Pfizer Is on Our Minds Today
In this Market Foolery podcast, and with the big news coming out of healthcare, host Chris Hill calls upon the expert insight of Industry Focus: Healthcare host Kristine Harjes.First, they....